Lv41
500 积分 2026-07-06 加入
Improving outcomes of patients with pancreatic cancer
15天前
已完结
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer
15天前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
15天前
已完结
Bridging the Gap: Molecular Profiling to Guide Treatment Selection in Metastatic Pancreatic Cancer
22天前
已完结
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer
22天前
已完结
The tumour microenvironment in pancreatic cancer — new clinical challenges, but more opportunities
22天前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
26天前
已完结
Improving outcomes of patients with pancreatic cancer
26天前
已完结
Identification of patients with advanced pancreatic cancer who might benefit from third-line chemotherapy
1个月前
已关闭
Adoption of Broad Genomic Profiling in Patients With Cancer
1个月前
已完结
皖公网安备34019202002308
